source
- Boulevard Bio raises $65M to expand immunology pipeline, eyes Vera's IgAN candidateBoulevard Bio announced it has secured $65 million in financing to broaden its immunology portfolio. The new capital will support the development of two immune‑resetting drugs the company discovere…
- Definium's LSD drug clears bar in first of two Phase 3 anxiety disorder trialsDefinium Therapeutics said Wednesday its oral LSD candidate has passed a late-stage study in generalized anxiety disorder (GAD), not even two months after reporting trial success for the same asset…Endpoints · 38m ago↗ source